Université Paris Descartes

Featured in: Favicon

nature.com Favicon

wiley.com (+1) Favicon

springer.com Favicon

plos.org (+1) Favicon

sciencedirect.com Favicon

theconversation.com Favicon

bmj.com (+10) Favicon

tandfonline.com Favicon

frontiersin.org + 52 more

Articles

Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study

Sep 20, 2024 | academic.oup.com | Université de Lorraine |Université Paris Descartes |Université de Bordeaux |IHU Liryc
Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study

Sep 19, 2024 | academic.oup.com | Université de Lorraine |Université Paris Descartes |Université de Bordeaux |IHU Liryc
Assessing post-abortion care using the WHO quality of care framework for maternal and newborn health: a cross-sectional study in two African hospitals in humanitarian settings | Reproductive Health | Full Text

Aug 4, 2024 | reproductive-health-journal.biomedcentral.com | Mariette Claudia |Médecins Sans Frontières |Université Paris Descartes

This study was part of the AMoCo (Abortion-related Morbidity and mortality in fragile and Conflict-affected settings) study.
CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions - Acta Neuropathologica Communications

Jan 18, 2024 | actaneurocomms.biomedcentral.com | Institut Imagine |Université Paris Descartes

ReferencesWHO Classification of Tumours Editorial Board (2022) Haematolymphoid Tumours. Lyon (France): International Agency for Research on Cancer. WHO classification of tumours series, 5th Edn. Vol. 11Yang Y, Shu Y, Tang Y, Zhao S, Jia Y, Ji J et al (2023) RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification.
Frontiers Corrigendum Template for Authors

Nov 14, 2023 | frontiersin.org | Université Paris Descartes |CHU Montpellier |Universite Montpellier

Antonio Bulbena1, 2* Silvia Rosado3, 4 Marina Cabaleiro2, 3 maria martinez2, 3 Carolina Baeza-Velasco5, 6, 7 Luis M Martin3 Santiago Batlle-Vila3 Andrea Bulbena8 1Institut de Neuropsiquiatria i Addiccions (INAD), Spain 2Department of Psychiatry and Forensic Medicine, School of Medicine, Autonomous University of Barcelona, Spain 3Institut de Neuropsiquiatria i Addiccions (INAD), Spain 4Department of Psychiatry and Forensic Medicine, School of Medicine, Autonomous University of Barcelona, Spain...
T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID

Nov 8, 2023 | frontiersin.org | Université Paris Descartes |Jean Yves

Cezar Renaud1 Lucy Kundura2 Sonia André3 Claire Lozano4 Thierry Vincent4 Laurent Muller1 Jean Yves LEFRANT1 Claire Roger1 Pierre-Géraud Claret1 Sandra Duvnjak1 Paul Loubet1 Albert Sotto1 Tu-Ahn Tran1 JEROME ESTAQUIER5 PIERRE CORBEAU1, 2, 6* 1Centre Hospitalier Universitaire de Nîmes, France 2Institut de Génétique Humaine, Université de Montpellier, France 3Université Paris Descartes, France 4Centre Hospitalier Universitaire de Montpellier, France 5Laval University, Canada 6Université de...
Heart and systemic sclerosis-findings from a national cohort study

Nov 7, 2023 | academic.oup.com | Hôpital Saint-Antoine |Université Paris Descartes |Systemic Diseases

Heart involvement is one of the leading causes of death in systemic sclerosis (SSc). The prevalence of SSc-related cardiac involvement is poorly known. Our objective was to investigate the prevalence and prognosis burden of different heart diseases in a nationwide cohort of patients with SSc. We used data from a multicentric prospective study using the French SSc national database. Focusing on SSc-related cardiac involvement, we aimed to determine its incidence and risk factors.
Insights from ASCO 2023

Sep 26, 2023 | karger.com | Campus Lübeck |Université Paris Descartes |Martin-Luther-University Halle-Wittenberg

Janni: In my opinion, the strength of the NATALEE data is the new treatment option in intermediate risk patients beyond the high-risk situation represented by the MonarchE cohort. In future, I will consider treating these patients according to the trial. In our high-risk patients, we will have two treatment options in future, which are great, given different toxicity profiles. Banys-Paluchowski: This is a very exciting question.
An Introduction to Individual Participant Data Meta-analysis

Jun 5, 2023 | n.neurology.org | Areti Angeliki Veroniki |Université Paris Descartes |Georgios Seitidis |Georgios Tsivgoulis

REQUIREMENTSYou must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information. Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →